Cytek Biosciences, Inc. Common Stock (CTKB) is a publicly traded Healthcare sector company. As of July 16, 2026, CTKB trades at $4.70 with a market cap of $596.64M and a P/E ratio of 0.00. CTKB moved +0.65% today. Year to date, CTKB is -7.92%; over the trailing twelve months it is +43.08%. Its 52-week range spans $2.37 to $7.30. Analyst consensus is buy with an average price target of $5.69. Rallies surfaces CTKB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CTKB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $4.70 |
| Market Cap | $596.64M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.30 |
| 52-Week Low | $2.37 |
| Volume | 472.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $201.49M |
| Net Income | $-66.54M |
| Gross Margin | 51.84% |
4 analysts cover CTKB: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.69.